曝光臺(tái) 注意防騙 網(wǎng)曝天貓店富美金盛家居專營店坑蒙拐騙欺詐消費(fèi)者

Abnormalities, disabilities and functional capacity
1.1 Has no safety-relevant condition of any of the following kinds that
produces any degree of functional incapacity or a risk of incapacitation:
(a) an abnormality;
(b) a disability or disease (active or latent);
(c) an injury;
(d) a sequela of an accident or a surgical operation
1.2 Has no physical conditions or limitations that are safety-relevant
1.3 Is not using any over-the-counter or prescribed medication or drug
(including medication or a drug used to treat a disease or medical
disorder) that causes the person to experience any side effects likely to
affect the person to an extent that is safety-relevant
Mental fitness
1.4 Has no established medical history or clinical diagnosis of any of the
following conditions, to an extent that is safety-relevant:
(a) psychosis;
(b) significant personality disorder;
(c) significant mental abnormality or neurosis
1.5 Does not engage in any problematic use of substances (within the
meaning given by section 1.1 of Annex 1, Personnel Licensing, to the
Chicago Convention)
1.6 If there is any personal history of problematic use of a substance
(within the meaning given by section 1.1 of Annex 1, Personnel
Licensing, to the Chicago Convention):
(a) the person’s abstinence from problematic use of the substance is
certified by an appropriate specialist medical practitioner; and
(b) the person is not suffering from any safety-relevant sequelae
resulting from the person’s use of the substance; and
Civil Aviation Safety Regulations 1998 (CASR)
CASR – 1st Edition – January 2003 Office of Legal Counsel
Replacement Page Amdt No. 11 – Dsecember 2004 Civil Aviation Safety Authority
Part 67 — 22
Item Criterion
(c) the person provides evidence that the person is undertaking, or
has successfully completed, an appropriate course of therapy
Note In Annex 1, Personnel Licensing, to the Chicago Convention,
‘Problematic use of substances’ is defined as follows:
‘The use of one or more psychoactive substances by aviation personnel in a
way that:
a) constitutes a direct hazard to the user or endangers the lives, health or
welfare of others; and/or
b) causes or worsens an occupational, social, mental or physical problem
or disorder.’.
‘Psychoactive substances’ is there defined as ‘Alcohol, opioids, cannabinoids,
sedatives and hypnotics, cocaine, other psychostimulants, hallucinogens, and
volatile solvents, whereas coffee and tobacco are excluded.’.
Nervous system
1.7 Has no established medical history or clinical diagnosis of:
(a) a safety-relevant disease of the nervous system; or
(b) epilepsy; or
(c) a disturbance of consciousness for which there is no satisfactory
medical explanation and which may recur
1.8 Is not suffering from safety-relevant effects of a head injury or
neurosurgical procedure
Cardiovascular system
1.9 Has no safety-relevant heart abnormality
1.10 Systolic and diastolic blood pressures are within limits specified by
CASA from time to time in the Designated Aviation Medical
Examiner’s Handbook (even if approved drugs are used to maintain the
blood pressure within those limits)
1.11 Has no significant functional or structural abnormality of the
circulatory tree
Respiratory system
1.12 Is not suffering from a safety-relevant condition of the respiratory
system
1.13 Has full and free respiratory function without the use of drugs (other
than drugs approved by CASA for this item) that act on the respiratory
organs
Alimentary system and metabolic disorders
1.14 Is not suffering from any safety-relevant defect of the digestive system
or its adnexae, nor from any safety-relevant effect of disease or trauma
of, or an operation on, the digestive system or its adnexae
1.15 Is not suffering from any safety-relevant metabolic, nutritional or
endocrine disorders
1.16 If suffering from diabetes mellitus — the diabetes is satisfactorily
controlled without the use of any anti-diabetic drug
Reticulo-endothelial system
1.17 Is not suffering from an enlargement of the spleen that causes a
significant displacement below the costal margin
Civil Aviation Safety Regulations 1998 (CASR)
CASR – 1st Edition – January 2003 Office of Legal Counsel
New Page – Amdt No. 3 – 3 September 2003 Civil Aviation Safety Authority
Part 67 — 23
1.18 Is not suffering from a safety-relevant condition of any of the following
kinds:
(a) localised or generalised enlargement of the lymphatic nodes;
　
中國航空網(wǎng) www.k6050.com
航空翻譯 www.aviation.cn
本文鏈接地址：澳大利亞CASR Civil Aviation Safety Regulations中(27)